4-methyl-5-(1H-pyrazol-3-yl)-2-p-tolylthiazole

ID: ALA4756395

Cas Number: 1397224-18-8

PubChem CID: 45588555

Max Phase: Preclinical

Molecular Formula: C14H13N3S

Molecular Weight: 255.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2nc(C)c(-c3cc[nH]n3)s2)cc1

Standard InChI:  InChI=1S/C14H13N3S/c1-9-3-5-11(6-4-9)14-16-10(2)13(18-14)12-7-8-15-17-12/h3-8H,1-2H3,(H,15,17)

Standard InChI Key:  OWUYIJUAGSAJFL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   23.0337  -18.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8353  -18.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1674  -19.5044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.9801  -19.4193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.1504  -18.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4428  -18.2113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7005  -17.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8867  -17.9377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7203  -18.7393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4314  -19.1451    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.9796  -19.0756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3160  -18.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5717  -18.9322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4897  -19.7461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1581  -20.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8998  -19.8855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7452  -20.0831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1065  -17.1390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  2  1  0
  1  2  1  0
  1  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  1  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 11  1  0
 14 17  1  0
  7 18  1  0
M  END

Associated Targets(Human)

COMT Tclin Catechol O-methyltransferase (404 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 255.35Molecular Weight (Monoisotopic): 255.0830AlogP: 3.82#Rotatable Bonds: 2
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.94CX Basic pKa: 2.00CX LogP: 3.64CX LogD: 3.64
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -1.99

References

1. Lerner C,Jakob-Roetne R,Buettelmann B,Ehler A,Rudolph M,Rodríguez Sarmiento RM.  (2016)  Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket.,  59  (22): [PMID:27685665] [10.1021/acs.jmedchem.6b00927]
2. Dechering K; Duffey M.  (2022)  Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum ,using a nano luciferase reporter read-out,  [10.6019/CHEMBL4888484]